[Edaily Reporter Kwon Oh Seok ] The Financial Supervisory Service announced on the 9th that it had issued a correction order to HUMAX CO., LTD.(115160)and Humax Holdings Co., Ltd(028080)regarding their merger decision, citing significant omissions or false statements in the Key Facts Report and Securities Registration Statement—specifically concerning important matters related to investment decisions. Previously, HUMAX CO., LTD. had pursued an absorption merger with its holding company, Humax Holdings Co., Ltd., to address the risk of delisting due to its low market capitalization.
Disclosure Plus
FSS Puts the Brakes on HUMAX CO., LTD. and Humax Holdings Co., Ltd. Merger… Issues Correction Order
Kwon Oh Seok
2026-07-09 17:18:13
Economy
Corporation
IT·Science
Economy
"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
Corporation
Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
IT·Science
SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
